Vivodyne, Inc. is an exciting startup from Penn Bioengineering that’s creating a platform technology to answer a pressing question in biotech: how can we improve the accuracy, speed, and breadth of the modern drug development pipeline?
They are creating a groundbreaking 3D tissue culture pipeline and statistical inference engine to test drugs, biologics, and immunotherapies directly on ultra-realistic , bioengineered human tissues. All at pharmaceutical-grade throughput.
Startup Details
Founded by:
- Donguen (Dan) Huh, PhD
- Andrei Georgescu, PhD candidate
Counsel: Cooley
Seed Investor: Kairos